Vascular normalisation as the stepping stone into tumour microenvironment transformation.
Anette L Magnussen1, Ian G Mills2,3,4,5
1Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.
British Journal of Cancer
|April 8, 2021
Summary
Vessel normalization, which remodels tumor vasculature, improves anti-cancer drug delivery and treatment response. This strategy helps manage cancer by optimizing the tumor microenvironment and reducing metastasis.
Area of Science:
- Oncology
- Vascular Biology
- Cancer Therapeutics
Background:
- A functional tumor vascular system is crucial for drug delivery and the tumor microenvironment's response to medication.
- Tumor progression involves cancer cell interactions with the tumor microenvironment, including neovessels.
- The vascular network is a primary route for tumor cell dissemination and metastasis.
Purpose of the Study:
- To reconcile the dual role of tumor vasculature in drug delivery and metastasis.
- To explore the benefits of vessel normalization in anti-cancer treatments.
- To understand how vascular normalization impacts the tumor microenvironment and disease management.
Main Methods:
- Reviewing current literature on tumor neovascularization and vessel normalization.
- Analyzing the causality between normalized vasculature and improved treatment outcomes.
- Highlighting challenges in controlled neovascular remodeling.
Main Results:
- Vessel normalization, involving pruning of redundant vessels and stabilization of abnormal vasculature, is beneficial for anti-cancer treatments.
- A direct link exists between normalized vasculature and enhanced response to medication.
- Modulating vasculature can advantageously shape disease management strategies.
Conclusions:
- Vessel normalization presents a promising strategy to improve cancer therapy by optimizing the tumor microenvironment.
- Controlled neovascular remodeling is challenging but essential for effective cancer treatment.
- Understanding and manipulating vascular normalization can significantly impact cancer disease management.
Related Concept Videos
The Tumor Microenvironment
7.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K
Metastasis
6.0K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.0K
Regulation of Angiogenesis and Blood Supply
3.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K


